Max Healthcare CMD to attend Kotak investor conference in London

Max Healthcare Institute Limited announced its Chairman and Managing Director will participate in the Kotak India Corporate Day 2026 investor conference scheduled for June 15, 2026. The meeting will be conducted physically at the InterContinental London and will include one-on-one and group interactions. The company confirmed that no unpublished price sensitive information is proposed to be shared during the conference.

The disclosure was made to the National Stock Exchange of India Limited and BSE Limited in reference to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The schedule is subject to changes due to exigencies on the part of the investors or the company.

Conference Details

The following table outlines the specifics of the investor conference participation:

Date & Day	Particulars	Mode of Meeting	Type of Meeting	Location
June 15, 2026 (Monday)	Kotak India Corporate Day 2026	Physical	One on one & Group Meeting	InterContinental London

Dhiraj Aroraa, Executive Vice President - Company Secretary and Compliance Officer, signed the disclosure on behalf of Max Healthcare Institute Limited. The information will also be hosted on the company's official website.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
-0.05%	+4.56%	-0.29%	-6.27%	-14.62%	+293.91%

Promoters of Max Healthcare Institute Limited have confirmed that no shares of the company were encumbered during the financial year 2025-26. Abhay Soi, a promoter, and Aditya Soi, a member of the promoter group, declared that they have not created any encumbrance on the shares of the company, either directly or indirectly, throughout the period. This disclosure ensures that the promoter group's shareholding remains free from charges or pledges, which is a key indicator of financial stability for investors.

The declaration was submitted to the National Stock Exchange of India Limited and BSE Limited on April 06, 2026. The filing was made in compliance with Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. This regulation requires promoters to disclose any encumbrance on their holdings to ensure transparency in the shareholding structure of listed entities.

Entity	Role	Encumbrance Status
Abhay Soi	Promoter	No encumbrance
Aditya Soi	Promoter Group Member	No encumbrance

The disclosure was addressed to the Listing Departments of both exchanges and copied to the Chairman and the Audit Committee of Max Healthcare Institute Limited. The company's scrip code on the BSE is 543220, and it trades under the symbol MAXHEALTH.